Unsuitable practice of folic acid supplementation in pregnant women in Hungary;A magyarországi várandósok folsavszedési szokásai

Orvosi Hetilap

Volumn 147, Issue 34, 2006, Pages 1633-1638

  Bognár, Márta ^a   Hauser, Péter ^b   Jakab, Zsuzsa ^b   Müller, Judit ^b   Constantin, Tamás ^b   Schuler, Dezso ^b   Garami, Miklós ^b,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b II Gyermekgyógyászati Klinika   (Hungary)

^c NONE   (Hungary)

Author keywords

Folic acid; Formation of neutral tube; Intake of folic acid; Prevention

Indexed keywords

FOLIC ACID;

ARTICLE; CANADA; CANCER REGISTRY; CLINICAL PRACTICE; COMPUTER ANALYSIS; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NEUROBLASTOMA; PREGNANCY; PREGNANT WOMAN; QUESTIONNAIRE; REGISTER; TIME SERIES ANALYSIS; VITAMIN SUPPLEMENTATION; ADULT; HUNGARY;

ADULT; FEMALE; FOLIC ACID; HUMANS; HUNGARY; INCIDENCE; NEURAL TUBE DEFECTS; NEUROBLASTOMA; PREGNANCY; QUESTIONNAIRES; REGISTRIES;

EID: 33750575355     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Beke A.: Felkészülés és felkészítés a terhességre. in A várandós no gondozása. Szerk.: Rigó J. Jr., Papp Z. Medicina Könyvkiadó Rt., Budapest, 2005, 65-74. old.
2. Berry R. J., Li, Z., Erickson J. D. és mtsai: Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med., 1999, 341, 1485-1490.
3. Bower, C., Stanley, F. J.: Dietary folate as a risk factor for NTDs: Evidence from a case control study in Western Australia. Med. J. Aus., 1989, 150, 613-619.
4. Czeizel, A. E., Dudas, I.. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med., 1992, 327, 1832-1835.
5. DHHS, Food and Drug Administration: Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register, 1996, 61, 8781-8797.
6. French, A. E., Grant, R., Weitzman, S. és mtsai: Folic acid food fortification is associated with a decline in neuroblastoma. Clin. Pharmacol. Ther., 2003, 74, 288-294.
7. Honein, M. A., Paulozzi, L. J., Mathews, T. J. és mtsai: Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA, 2001, 285, 2981-2986.
8. Kirke, P. N., Molloy, A. M., Daly, L. E. és mtsai: Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med., 1993, 86, 703-708.
9. Laurence, K. M., James, N., Miller, M. H. és mtsai: Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br. Med. J. (Clin. Res. Ed.), 1981, 282, 1509-1511.
10. Mills, J. L.: Fortification of Foods with Folic Acid - How Much is Enough? N. Engl. J. Med., 2000, 342, 1442-1445.
11. Mills, J. L., Von Kohorn, I., Conley, M. R. és mtsai: Low vitamin B-12 concentrations in patients without anaemia: the effect of folic acid fortification of grain. Am. J. Clin. Nutr., 2003, 77, 1474-1477.
12. Milunsky, A., Jick, H., Jick, S. S. és mtsai: Multivitamin/ folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA, 1989, 262, 2847-2852.
13. MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet, 1991, 338, 131-137.
14. Mulinare, J., Cordero, J. F., Erickson, J. D. és mtsa: Periconceptional use of multivitamins and the occurrence of neutral tube defects. JAMA, 1988, 260, 3141-3145.
15. Recommendations for the use of folic acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects. MMWR Reccomm. Rep., 1992, 41, 1-7.
16. Shaw, G. M., Schaffer, D., Velie, E. M. és mtsai: Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology, 1995, 6, 219-226.
17. Smithells, R. W., Nevin, N. C., Seller, M. J. és mtsai: Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet, 1983, 1, 1027-1031.
18. Smithells, R. W., Hibbard, E.D.: Folic acid metabolism and human embryopathy. Lancet, 1965, 1, 1254-1256.
19. Szülészeti és Nogyógyászati Szakmai Kollégium 1998. szeptember 25-ei szakmai állásfoglalása a terhesség alatti vitamin és ásványianyag supplementatio kérdésrol. Magyar Noorvosok Lapja, 1999, 62, 63-65.
20. Toriello, H. V., Professional Practice and Guidelines Committee, American College of Medical Genetics: Folic acid and neural tube defects. Genet. Med., 2005, 7, 283-284.
21. Vergel, R. G., Sanchez, L. R., Heredero, B. L. és mtsai: Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat. Diagn., 1990, 10, 149-152.
22. Wald, N. J.: Folic acid and the prevention of neural-tube defects. N. Engl. J. Med., 2004, 350, 101-103.
23. Wald, N. J., Law, M., Hoffbrand, A. V.: Folic acid fortification in the prevention of neural tube defects. Am. J. Clin. Nutr., 2004, 80, 1665-1666.
24. Wald, N. J., Law, M. R., Morris, J. K. és mtsa: Quantifying the effect of folic acid. Lancet, 2001, 358, 2069-2073.
25. Williams, L. J., Mai, C. T., Edmonds, L. D. és mtsai: Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology, 2002, 66, 33-39.